中山大便中间带血(中山肛门长一个小肉) (今日更新中)

HANOI, Oct. 7 (Xinhua) -- Vietnam in cooperation with the United Nations Development Program (UNDP) and the Food and Agriculture Organization (FAO) organized a workshop here on Friday to finalize implementations in Phase 2 of the UN-Vietnam Joint Program to fight against Highly Pathogenic Avian Influenza (HPAI) during 2007-2011.The workshop is not only to review the achievements but also from that, Vietnam hopes to receive more supports from the UN agencies, said Bui Ba Bong, Vietnamese vice minister of Agriculture and Rural Development.According to the report, so far, Vietnam's project on prevention of HPAI has basically achieved the targets in terms of making plans, policies and strategies for the veterinary sector, assessing the impacts of destruction of poultry to the environment, controlling pandemic, and supporting vaccine inoculation, quarantine and control of the infected animals, said Bong.Vietnam showed great efforts in responding and preventing H5N1 pandemic during its occurrence in 2005-2006, evaluated UN agencies.In Phase 2, Vietnam achieved positive results in controlling and reducing the impacts of the pandemic, and promoting bio- security in livestock breeding. Therefore, UN pledged to continue assisting Vietnam in the future.The UN-Vietnam joint program to fight HPAI was designed to meet the needs of emergency assistance to control the avian and human influenza.Total fund of the program is 25 million U.S. dollars, of which over 18 million U.S. dollars was approved for Phase 2.

BEIJING, Oct. 11 (Xinhuanet) -- An experimental drug that can remove amyloid plaques from the brains of Alzheimer's patients is being developed by Swiss Roche Holding AG in a small early-stage study, according to a report published in the Archives of Neurology on Monday.Researchers suspect the build-up of such plaques may be a cause of the memory robbing disease, although that theory has yet to be definitively proved. Gantenerumab, a biotech drug designed to bind to amyloid plaques in the brain and remove them, is being targeted at the early stages of Alzheimer's with the hope it can slow progression of the disease while patients are still able to function.The Phase I study of 16 Alzheimer's patients tested gantenerumab at two doses against a placebo over six months of treatment.The Roche drug led to a dose-dependent reduction of brain amyloid, while amyloid load increased in patients receiving a placebo, the report said.The next step will be to investigate whether removal of brain amyloid translates into clinical benefit for patients at doses of the experimental drug that are well tolerated and safe, the report said.Much larger trials and further study will be needed to fully understand how gantenerumab works and whether it can stave off Alzheimer's, said the report.Roche is approaching the disease far earlier because amyloid accumulates for 15 years before dementi.

BEIJING, Dec. 7 (Xinhua) -- China backs European efforts for further integration and supports current initiatives by the European Union to tackle the debt crisis, Chinese Foreign Ministry spokesman Hong Lei said Wednesday.Hong told a regular press briefing that China will work with the international community to help stabilize the global financial market and promote the recovery and growth of the world economy."We have noted that the EU has made a series of important proposals to address the European sovereign debt crisis and we hope such proposals can work to help stabilize the market, restore market faith and prevent the crisis from deteriorating," Hong added.Europe's powerhouses France and Germany agreed Monday on a series of reforms aimed at changing the European Union treaty to impose tough controls on eurozone budgets.The new treaty would include automatic sanctions for states that fail to observe the 3 percent deficit rule, as well as a budget-balancing rule across the eurozone.New and significant decisions to tackle the crisis might be made during the EU summit to be held from Dec. 8 to 9, Hong predicted.Leaders from the 27 member states of the European Union will meet in Brussels on Dec. 8-9 to discuss how to resolve the eurozone crisis.

BEIJING, Oct. 13 (Xinhuanet) -- Scientists have decoded the genome of Black Death which caused one of the worst plagues in human history.The finding was published Wednesday in the scientific journal Nature.A team of German, Canadian and American scientists collected the bacteria's DNA from ancient plague victims' teeth and bones, which were excavated from the burial ground in London.With a careful NDA comparison between the ancient bacteria and the modern strains, scientists found the direct variant of the medieval bacteria still exist today.Black Death's descendants kill around 2,000 people a year, mostly in the developing world, the scientist said."This will provide us with direct insights into the evolution of human pathogens and historical pandemics," said Johannes Krause Of Germany's University of Tubingen, who worked on the study.Black Death, the fatal plague of medieval Europe, wiped out some 30 million people -- about 50 percent of the population on the continent, within just five years, between 1347 and 1351.

BEIJING, Nov. 28 (Xinhuanet) -- Scientists in Canada have raised a prospect of reversing Alzheimer's disease by deep brain stimulation, according to media reports Monday.The technique here is known as deep brain stimulation -- applying electricity directly to regions of the brain. It has been used in tens of thousands of patients with Parkinson's as well as having an emerging role in Tourette's Syndrome and depression.The study at the University of Toronto took six patients with the condition. Deep brain stimulation was applied to the fornix -- a part of the brain which passes messages onto the hippocampus.Lead researcher Prof Andres Lozano said you would expect the hippocampus to shrink by five per cent on average in a year in patients with Alzheimer's.After 12 months of stimulation, he said one patient had a five per cent increase and another had an eight per cent increase.Prof Lozano told BBC: "This is the first time that brain stimulation in a human being has been shown to grow an area of your brain.""It was an amazing finding for us," he said.The findings were presented at the Society for Neuroscience conference in November but they have yet to be published in an academic journal.To test whether this is really working, rather than being a fluke result, the researchers are going to perform a larger trial.

来源：资阳报